PRTA Q4 2021 Earnings — Prothena Corporation plc Revenue & Financial Results | Market Cap Arena

PRTAProthena Corporation plc

$549M

Q4 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M+225.6% YoY

Gross Profit

-$21M-1782.1% margin

Operating Income

-$33M-2823.5% margin

Net Income

-$33M-2831.0% margin

EPS (Diluted)

$-0.71

QoQ Revenue Growth

-99.2%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$23M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$609M

Total Liabilities

$143M

Stockholders' Equity

$466M

Cash & Equivalents

$579M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$360,000	+225.6%
Gross Profit	-$21M	-$20M	-2.4%
Operating Income	-$33M	-$30M	-9.2%
Net Income	-$33M	-$31M	-8.0%

Revenue Segments

Collaboration

$1M100%